Regulation of bone mass in endocrine diseases including diabetes

Claire Higham; Bo Abrahamsen

doi:10.1016/j.beem.2022.101614

Regulation of bone mass in endocrine diseases including diabetes

Claire Higham, Bo Abrahamsen^*

^*Corresponding author af dette arbejde

Medicin 1

Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

Abstract

Hormonal regulation plays a key role in determining bone mass in humans. Both skeletal growth and bone loss in health and disease is critically controlled by endocrine factors and low bone mass is a feature of both excess and deficiency of a broad range of hormones. This article explores the impact of diabetes and thyroid, parathyroid, sex steroid and growth hormone disorders on bone mass and fracture risk. Evidence for current management strategies is provided along with suggested practice points and gaps in knowledge for future research.

Originalsprog	Engelsk
Artikelnummer	101614
Tidsskrift	Best Practice and Research in Clinical Endocrinology and Metabolism
Vol/bind	36
Udgave nummer	2
Tidlig onlinedato	21 jan. 2022
DOI	https://doi.org/10.1016/j.beem.2022.101614
Status	Udgivet - mar. 2022

Bibliografisk note

Adgang til dokumentet

10.1016/j.beem.2022.101614

Citationsformater

@article{b9220ba0482f47c9af65286700f88965,

title = "Regulation of bone mass in endocrine diseases including diabetes",

abstract = "Hormonal regulation plays a key role in determining bone mass in humans. Both skeletal growth and bone loss in health and disease is critically controlled by endocrine factors and low bone mass is a feature of both excess and deficiency of a broad range of hormones. This article explores the impact of diabetes and thyroid, parathyroid, sex steroid and growth hormone disorders on bone mass and fracture risk. Evidence for current management strategies is provided along with suggested practice points and gaps in knowledge for future research.",

keywords = "thyrotoxicosis, primary hyperparathyroidism, type 1 and type 2 diabetes mellitus, Cushing's syndrome, growth hormone, low bone mass",

author = "Claire Higham and Bo Abrahamsen",

year = "2022",

month = mar,

doi = "10.1016/j.beem.2022.101614",

language = "English",

volume = "36",

journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",

issn = "1521-690X",

publisher = "Bailliere Tindall Ltd",

number = "2",

}

TY - JOUR

T1 - Regulation of bone mass in endocrine diseases including diabetes

AU - Higham, Claire

AU - Abrahamsen, Bo

PY - 2022/3

Y1 - 2022/3

N2 - Hormonal regulation plays a key role in determining bone mass in humans. Both skeletal growth and bone loss in health and disease is critically controlled by endocrine factors and low bone mass is a feature of both excess and deficiency of a broad range of hormones. This article explores the impact of diabetes and thyroid, parathyroid, sex steroid and growth hormone disorders on bone mass and fracture risk. Evidence for current management strategies is provided along with suggested practice points and gaps in knowledge for future research.

AB - Hormonal regulation plays a key role in determining bone mass in humans. Both skeletal growth and bone loss in health and disease is critically controlled by endocrine factors and low bone mass is a feature of both excess and deficiency of a broad range of hormones. This article explores the impact of diabetes and thyroid, parathyroid, sex steroid and growth hormone disorders on bone mass and fracture risk. Evidence for current management strategies is provided along with suggested practice points and gaps in knowledge for future research.

KW - thyrotoxicosis

KW - primary hyperparathyroidism

KW - type 1 and type 2 diabetes mellitus

KW - Cushing's syndrome

KW - growth hormone

KW - low bone mass

U2 - 10.1016/j.beem.2022.101614

DO - 10.1016/j.beem.2022.101614

M3 - Review

C2 - 35120802

SN - 1521-690X

VL - 36

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

IS - 2

M1 - 101614

ER -

Regulation of bone mass in endocrine diseases including diabetes

Abstract

Bibliografisk note

Adgang til dokumentet

Fingeraftryk

Citationsformater